Meetings

During the webinar, Drs. White and Nezalova-Henriksen will present two articles related to: (a) Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic HSCT for older patients with AML or MDS and (b) Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients.

Join us for an expert-led session exploring the rising concern of measles outbreaks and their unique risks for patients undergoing Hematopoietic Cell Transplantation (HCT) and CAR T-cell therapies.

Join us for this overview of recent developments in cord blood transplant for heme malignancies. Our focus will be on manipulated graft sources and insights from real world use of expanded cord blood.

This live session will focus on two core topics in the field - CAR T and Gene Therapy. The faculty below will briefly present slides on their topic, and then answer questions and share their experiences from their institutions.

The Joint ASTCT + EBMT Basic and Translational Scientific Meeting is a 2.5-day conference focused on cutting-edge basic and translational biology in the field. The meeting focuses on fundamental themes and novel technologies with an emphasis on unpublished and innovative science.

Join ASTCT Director of Government Relations, Alycia Maloney, JD, and the reimbursement and policy advisors to ASTCT from Nimitt Consulting, for the Medicare FY 2026 IPPS Proposed Rule webinar.r on May 15 at 12 p.m. CDT.